Stephen Davis - CEO, Director at Acadia Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
ACAD on Nasdaq
All Insider Reports
All Insider Reports

Stephen Davis - trading volume in the past year for Acadia Pharmaceuticals Inc

Holdings reported by Stephen Davis for Acadia Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 187K $2.85M $15.28 Aug 19, 2024 Direct
Restricted Stock Units 67.2K $1.2M $17.87 May 1, 2024 Direct Common Stock
Stock Option (Right to Buy) 286K Mar 25, 2024 Direct Common Stock

Transactions reported by Stephen Davis for Acadia Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.